Annual CFF
-$3.62 B
-$812.00 M-28.90%
31 December 2023
Summary:
Thermo Fisher Scientific annual cash flow from financing activities is currently -$3.62 billion, with the most recent change of -$812.00 million (-28.90%) on 31 December 2023. During the last 3 years, it has fallen by -$4.58 billion (-477.69%). TMO annual CFF is now -155.04% below its all-time high of $6.58 billion, reached on 31 December 2021.TMO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$1.19 B
-$1.07 B-934.78%
28 September 2024
Summary:
Thermo Fisher Scientific quarterly cash flow from financing activities is currently -$1.19 billion, with the most recent change of -$1.07 billion (-934.78%) on 28 September 2024. Over the past year, it has dropped by -$3.04 billion (-164.15%). TMO quarterly CFF is now -114.05% below its all-time high of $8.47 billion, reached on 31 December 2021.TMO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$4.55 B
-$3.04 B-201.79%
28 September 2024
Summary:
Thermo Fisher Scientific TTM cash flow from financing activities is currently -$4.55 billion, with the most recent change of -$3.04 billion (-201.79%) on 28 September 2024. Over the past year, it has dropped by -$4.75 billion (-2411.68%). TMO TTM CFF is now -141.50% below its all-time high of $10.97 billion, reached on 29 March 2014.TMO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TMO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.9% | -164.2% | -2411.7% |
| 3 y3 years | -477.7% | -139.1% | -135.3% |
| 5 y5 years | -61.9% | +36.3% | -74.0% |
TMO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -155.0% | at low | -114.0% | +62.2% | -155.0% | at low |
| 5 y | 5 years | -155.0% | at low | -114.0% | +75.5% | -155.0% | +21.0% |
| alltime | all time | -155.0% | at low | -114.0% | +75.5% | -141.5% | +21.0% |
Thermo Fisher Scientific Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.19 B(+934.8%) | -$4.55 B(+201.8%) |
| June 2024 | - | -$115.00 M(-93.7%) | -$1.51 B(-47.1%) |
| Mar 2024 | - | -$1.82 B(+27.5%) | -$2.85 B(-21.3%) |
| Dec 2023 | -$3.62 B(+28.9%) | -$1.43 B(-177.0%) | -$3.62 B(-1938.6%) |
| Sept 2023 | - | $1.85 B(-227.4%) | $197.00 M(-110.9%) |
| June 2023 | - | -$1.46 B(-43.8%) | -$1.81 B(-19.9%) |
| Mar 2023 | - | -$2.59 B(-208.4%) | -$2.26 B(-19.6%) |
| Dec 2022 | -$2.81 B(-142.7%) | $2.39 B(-1683.4%) | -$2.81 B(-186.0%) |
| Sept 2022 | - | -$151.00 M(-92.1%) | $3.27 B(-49.4%) |
| June 2022 | - | -$1.91 B(-39.4%) | $6.46 B(-22.1%) |
| Mar 2022 | - | -$3.15 B(-137.1%) | $8.29 B(+25.9%) |
| Dec 2021 | $6.58 B(+586.2%) | $8.47 B(+178.5%) | $6.58 B(-440.1%) |
| Sept 2021 | - | $3.04 B(-4100.0%) | -$1.94 B(-66.4%) |
| June 2021 | - | -$76.00 M(-98.4%) | -$5.77 B(+27.8%) |
| Mar 2021 | - | -$4.85 B(+9798.0%) | -$4.51 B(-570.3%) |
| Dec 2020 | $959.00 M(-130.8%) | -$49.00 M(-93.8%) | $959.00 M(+94.1%) |
| Sept 2020 | - | -$791.00 M(-167.0%) | $494.00 M(-184.6%) |
| June 2020 | - | $1.18 B(+90.6%) | -$584.00 M(-45.6%) |
| Mar 2020 | - | $619.00 M(-220.4%) | -$1.07 B(-65.6%) |
| Dec 2019 | -$3.12 B(+39.4%) | -$514.00 M(-72.5%) | -$3.12 B(+19.1%) |
| Sept 2019 | - | -$1.87 B(-370.9%) | -$2.62 B(+61.1%) |
| June 2019 | - | $690.00 M(-148.4%) | -$1.62 B(-51.1%) |
| Mar 2019 | - | -$1.43 B(>+9900.0%) | -$3.32 B(+48.4%) |
| Dec 2018 | -$2.24 B(-158.0%) | -$13.00 M(-98.5%) | -$2.24 B(-33.6%) |
| Sept 2018 | - | -$876.00 M(-12.9%) | -$3.37 B(-193.8%) |
| June 2018 | - | -$1.01 B(+194.2%) | $3.59 B(-1.2%) |
| Mar 2018 | - | -$342.00 M(-70.1%) | $3.63 B(-5.8%) |
| Dec 2017 | $3.85 B(+39.7%) | -$1.14 B(-118.8%) | $3.85 B(+37.3%) |
| Sept 2017 | - | $6.08 B(-730.8%) | $2.81 B(+94.0%) |
| June 2017 | - | -$964.00 M(+710.1%) | $1.45 B(-3.4%) |
| Mar 2017 | - | -$119.00 M(-94.6%) | $1.50 B(-45.7%) |
| Dec 2016 | $2.76 B(-205.4%) | -$2.19 B(-146.4%) | $2.76 B(-32.4%) |
| Sept 2016 | - | $4.72 B(-616.9%) | $4.08 B(-379.7%) |
| June 2016 | - | -$913.30 M(-179.9%) | -$1.46 B(+6.1%) |
| Mar 2016 | - | $1.14 B(-231.3%) | -$1.37 B(-47.5%) |
| Dec 2015 | -$2.62 B(-154.6%) | -$869.90 M(+6.4%) | -$2.62 B(+57.9%) |
| Sept 2015 | - | -$817.80 M(-1.3%) | -$1.66 B(-15.2%) |
| June 2015 | - | -$828.90 M(+725.6%) | -$1.95 B(-33.5%) |
| Mar 2015 | - | -$100.40 M(-212.4%) | -$2.94 B(-161.3%) |
| Dec 2014 | $4.80 B(+44.9%) | $89.30 M(-108.0%) | $4.80 B(-40.3%) |
| Sept 2014 | - | -$1.11 B(-38.6%) | $8.03 B(-12.0%) |
| June 2014 | - | -$1.81 B(-123.8%) | $9.13 B(-16.8%) |
| Mar 2014 | - | $7.64 B(+129.7%) | $10.97 B(+231.5%) |
| Dec 2013 | $3.31 B(-460.7%) | $3.32 B(<-9900.0%) | $3.31 B(-633.1%) |
| Sept 2013 | - | -$15.60 M(-152.2%) | -$620.90 M(+1232.4%) |
| June 2013 | - | $29.90 M(-207.6%) | -$46.60 M(-87.1%) |
| Mar 2013 | - | -$27.80 M(-95.4%) | -$360.50 M(-60.7%) |
| Dec 2012 | -$917.70 M(-125.8%) | -$607.40 M(-208.7%) | -$917.70 M(+21.3%) |
| Sept 2012 | - | $558.70 M(-296.7%) | -$756.70 M(-148.6%) |
| June 2012 | - | -$284.00 M(-51.5%) | $1.56 B(+18.4%) |
| Mar 2012 | - | -$585.00 M(+31.0%) | $1.31 B(-63.0%) |
| Dec 2011 | $3.55 B(-374.2%) | -$446.40 M(-115.5%) | $3.55 B(-3.4%) |
| Sept 2011 | - | $2.87 B(-646.2%) | $3.67 B(+1039.5%) |
| June 2011 | - | -$525.70 M(-131.8%) | $322.50 M(-39.7%) |
| Mar 2011 | - | $1.65 B(-612.9%) | $534.50 M(-141.3%) |
| Dec 2010 | -$1.30 B(+132.3%) | -$322.00 M(-33.1%) | -$1.30 B(+15.1%) |
| Sept 2010 | - | -$481.30 M(+53.4%) | -$1.13 B(+72.5%) |
| June 2010 | - | -$313.70 M(+76.1%) | -$652.30 M(-12.5%) |
| Mar 2010 | - | -$178.10 M(+16.9%) | -$745.40 M(+33.7%) |
| Dec 2009 | -$557.50 M(+144.1%) | -$152.40 M(+1781.5%) | -$557.50 M(-8.8%) |
| Sept 2009 | - | -$8.10 M(-98.0%) | -$611.40 M(+7.4%) |
| June 2009 | - | -$406.80 M(-4251.0%) | -$569.10 M(+277.1%) |
| Mar 2009 | - | $9.80 M(-104.8%) | -$150.90 M(-33.9%) |
| Dec 2008 | -$228.40 M(-75.4%) | -$206.30 M(-703.2%) | -$228.40 M(-27.6%) |
| Sept 2008 | - | $34.20 M(+200.0%) | -$315.30 M(-58.8%) |
| June 2008 | - | $11.40 M(-116.8%) | -$764.40 M(-4.7%) |
| Mar 2008 | - | -$67.70 M(-76.9%) | -$802.30 M(-13.6%) |
| Dec 2007 | -$928.70 M | -$293.20 M(-29.3%) | -$928.70 M(+46.6%) |
| Sept 2007 | - | -$414.90 M(+1465.7%) | -$633.60 M(+99.9%) |
| June 2007 | - | -$26.50 M(-86.3%) | -$316.98 M(-26.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$194.10 M(<-9900.0%) | -$433.71 M(+66.7%) |
| Dec 2006 | -$260.10 M(-166.5%) | $1.90 M(-101.9%) | -$260.10 M(-11.3%) |
| Sept 2006 | - | -$98.29 M(-31.4%) | -$293.26 M(+19.2%) |
| June 2006 | - | -$143.23 M(+599.1%) | -$246.01 M(-167.0%) |
| Mar 2006 | - | -$20.49 M(-34.5%) | $367.11 M(-6.1%) |
| Dec 2005 | $390.86 M(-313.3%) | -$31.27 M(-38.7%) | $390.86 M(-10.5%) |
| Sept 2005 | - | -$51.03 M(-110.9%) | $436.93 M(+28.7%) |
| June 2005 | - | $469.89 M(>+9900.0%) | $339.62 M(-304.2%) |
| Mar 2005 | - | $3.27 M(-77.9%) | -$166.35 M(-9.2%) |
| Dec 2004 | -$183.22 M(-72.4%) | $14.80 M(-110.0%) | -$183.22 M(+11.8%) |
| Sept 2004 | - | -$148.34 M(+311.1%) | -$163.86 M(-19.7%) |
| June 2004 | - | -$36.09 M(+165.3%) | -$203.95 M(-49.0%) |
| Mar 2004 | - | -$13.60 M(-139.8%) | -$399.54 M(-39.8%) |
| Dec 2003 | -$663.63 M(+11.9%) | $34.17 M(-118.1%) | -$663.63 M(-20.1%) |
| Sept 2003 | - | -$188.43 M(-18.7%) | -$830.83 M(+4.8%) |
| June 2003 | - | -$231.68 M(-16.6%) | -$792.53 M(+14.5%) |
| Mar 2003 | - | -$277.69 M(+108.7%) | -$691.97 M(+16.7%) |
| Dec 2002 | -$592.97 M(-14.8%) | -$133.03 M(-11.4%) | -$592.97 M(-12.8%) |
| Sept 2002 | - | -$150.13 M(+14.5%) | -$680.13 M(-22.3%) |
| June 2002 | - | -$131.12 M(-26.6%) | -$874.97 M(+2.0%) |
| Mar 2002 | - | -$178.69 M(-18.9%) | -$857.71 M(+23.2%) |
| Dec 2001 | -$696.31 M(+406.1%) | -$220.19 M(-36.2%) | -$696.31 M(+55.3%) |
| Sept 2001 | - | -$344.97 M(+203.0%) | -$448.31 M(+274.2%) |
| June 2001 | - | -$113.86 M(+558.4%) | -$119.82 M(-21.1%) |
| Mar 2001 | - | -$17.29 M(-162.2%) | -$151.90 M(+10.4%) |
| Dec 2000 | -$137.58 M(-34.6%) | $27.81 M(-268.8%) | -$137.58 M(+46.4%) |
| Sept 2000 | - | -$16.48 M(-88.7%) | -$94.01 M(-51.1%) |
| June 2000 | - | -$145.94 M(+4803.9%) | -$192.22 M(+8.6%) |
| Mar 2000 | - | -$2.98 M(-104.2%) | -$177.02 M(-15.8%) |
| Dec 1999 | -$210.30 M(-197.0%) | $71.39 M(-162.2%) | -$210.30 M(+11.0%) |
| Sept 1999 | - | -$114.69 M(-12.3%) | -$189.39 M(-56.3%) |
| June 1999 | - | -$130.74 M(+260.6%) | -$433.80 M(+531.8%) |
| Mar 1999 | - | -$36.26 M(-139.3%) | -$68.66 M(-131.7%) |
| Dec 1998 | $216.90 M(+1.8%) | $92.30 M(-125.7%) | $216.90 M(+73.4%) |
| Sept 1998 | - | -$359.10 M(-253.2%) | $125.10 M(-81.6%) |
| June 1998 | - | $234.40 M(-6.0%) | $679.30 M(+44.7%) |
| Mar 1998 | - | $249.30 M(>+9900.0%) | $469.60 M(+120.4%) |
| Dec 1997 | $213.10 M(-79.5%) | $500.00 K(-99.7%) | $213.10 M(-32.6%) |
| Sept 1997 | - | $195.10 M(+689.9%) | $316.20 M(+100.3%) |
| June 1997 | - | $24.70 M(-443.1%) | $157.90 M(-59.8%) |
| Mar 1997 | - | -$7.20 M(-106.9%) | $392.30 M(-62.2%) |
| Dec 1996 | $1.04 B(+294.4%) | $103.60 M(+181.5%) | $1.04 B(+1.0%) |
| Sept 1996 | - | $36.80 M(-85.8%) | $1.03 B(-8.5%) |
| June 1996 | - | $259.10 M(-59.4%) | $1.12 B(+24.8%) |
| Mar 1996 | - | $638.50 M(+582.2%) | $900.30 M(+242.1%) |
| Dec 1995 | $263.20 M(-12.5%) | $93.60 M(-29.1%) | $263.20 M(+77.5%) |
| Sept 1995 | - | $132.10 M(+265.9%) | $148.30 M(+1529.7%) |
| June 1995 | - | $36.10 M(+2478.6%) | $9.10 M(-96.7%) |
| Mar 1995 | - | $1.40 M(-106.6%) | $275.90 M(-8.3%) |
| Dec 1994 | $300.90 M(-26.8%) | -$21.30 M(+200.0%) | $300.90 M(-20.5%) |
| Sept 1994 | - | -$7.10 M(-102.3%) | $378.40 M(-45.9%) |
| June 1994 | - | $302.90 M(+1047.3%) | $699.00 M(+71.0%) |
| Mar 1994 | - | $26.40 M(-53.0%) | $408.70 M(-0.6%) |
| Dec 1993 | $411.10 M(-1.6%) | $56.20 M(-82.1%) | $411.10 M(+5.1%) |
| Sept 1993 | - | $313.50 M(+2388.1%) | $391.20 M(+31.9%) |
| June 1993 | - | $12.60 M(-56.3%) | $296.50 M(-28.3%) |
| Mar 1993 | - | $28.80 M(-20.7%) | $413.70 M(-1.0%) |
| Dec 1992 | $417.70 M(+54.4%) | $36.30 M(-83.4%) | $417.70 M(-7.0%) |
| Sept 1992 | - | $218.80 M(+68.6%) | $449.10 M(+38.0%) |
| June 1992 | - | $129.80 M(+295.7%) | $325.50 M(+45.3%) |
| Mar 1992 | - | $32.80 M(-51.6%) | $224.00 M(-17.2%) |
| Dec 1991 | $270.60 M(+256.5%) | $67.70 M(-28.9%) | $270.60 M(+25.5%) |
| Sept 1991 | - | $95.20 M(+236.4%) | $215.70 M(+50.7%) |
| June 1991 | - | $28.30 M(-64.4%) | $143.10 M(-9.5%) |
| Mar 1991 | - | $79.40 M(+520.3%) | $158.10 M(+108.3%) |
| Dec 1990 | $75.90 M(-13.0%) | $12.80 M(-43.4%) | $75.90 M(+20.3%) |
| Sept 1990 | - | $22.60 M(-47.8%) | $63.10 M(+55.8%) |
| June 1990 | - | $43.30 M(-1646.4%) | $40.50 M(-1546.4%) |
| Mar 1990 | - | -$2.80 M | -$2.80 M |
| Dec 1989 | $87.20 M | - | - |
FAQ
- What is Thermo Fisher Scientific annual cash flow from financing activities?
- What is the all time high annual CFF for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific annual CFF year-on-year change?
- What is Thermo Fisher Scientific quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific quarterly CFF year-on-year change?
- What is Thermo Fisher Scientific TTM cash flow from financing activities?
- What is the all time high TTM CFF for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific TTM CFF year-on-year change?
What is Thermo Fisher Scientific annual cash flow from financing activities?
The current annual CFF of TMO is -$3.62 B
What is the all time high annual CFF for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high annual cash flow from financing activities is $6.58 B
What is Thermo Fisher Scientific annual CFF year-on-year change?
Over the past year, TMO annual cash flow from financing activities has changed by -$812.00 M (-28.90%)
What is Thermo Fisher Scientific quarterly cash flow from financing activities?
The current quarterly CFF of TMO is -$1.19 B
What is the all time high quarterly CFF for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high quarterly cash flow from financing activities is $8.47 B
What is Thermo Fisher Scientific quarterly CFF year-on-year change?
Over the past year, TMO quarterly cash flow from financing activities has changed by -$3.04 B (-164.15%)
What is Thermo Fisher Scientific TTM cash flow from financing activities?
The current TTM CFF of TMO is -$4.55 B
What is the all time high TTM CFF for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high TTM cash flow from financing activities is $10.97 B
What is Thermo Fisher Scientific TTM CFF year-on-year change?
Over the past year, TMO TTM cash flow from financing activities has changed by -$4.75 B (-2411.68%)